Pediatric Interventional Cardiology Market

Table Of Contents
 
1 Introduction (Page No. - 19)
   1.1 Objectives of the Study
   1.2 Report Description
   1.3 Markets Covered
   1.4 Stakeholders
   1.5 Scope
   1.6 Research Methodology
        1.6.1 Market Size Estimation
        1.6.2 Market Crackdown & Data Triangulation
        1.6.3 Market Share Calculation
        1.6.4 Key Data Points from Primary Sources
        1.6.5 Key Data Points from Secondary Sources
        1.6.6 Assumptions

2 Executive Summary (Page No. - 31)

3 Premium Insights (Page No. - 35)
   3.1 Investment Trends
   3.2 Technology Trends
   3.3 Regulatory Environment
        3.3.1 Regulatory Approval Procedures for Pediatric Cardiology Devices
               3.3.1.1 510(K) Application
               3.3.1.2 Premarket Approval (Pma) Application
               3.3.1.3 Humanitarian Device Exemption (Hde) Application
        3.3.2 Intellectual Property Protection and Patent Litigation
   3.4 Reimbursement Scenario: Transcatheter Heart Valves
   3.5 Porter’s Five Forces Analysis: Pediatric Interventional Cardiology Imaging Market
        3.5.1 Threat of New Entrants
        3.5.2 Bargaining Power of Suppliers
        3.5.3 Bargaining Power of Buyers
        3.5.4 Competitor Rivalry
        3.5.5 Threat of Substitutes
   3.6 Unmet Need
        3.6.1 Pediatric-Specific Cardiac Devices
   3.7 Winning Imperatives
        3.7.1 Investments in R&D Activities
        3.7.2 Acquisitions

4 Market Overview (Page No. - 49)
   4.1 Market Dynamics
        4.1.1 Market Drivers
               4.1.1.1 Pediatric Interventional Cardiology Devices
                        4.1.1.1.1 Government Support, An Impetus for the Pediatric Interventional Cardiology Market
                        4.1.1.1.2 Awareness Programs and Conferences to Fuel the Market
                        4.1.1.1.3 Rising Incidences of Congenital Heart Defects(CHD)to Propel the Pediatric Interventional Cardiology Market
                        4.1.1.1.4 Technological Advancements to Open New Opportunities for Device Manufacturers
                        4.1.1.1.5 Advantages of Minimally Invasive Procedures Over Conventional Surgeries to Propel the Market Growth
               4.1.1.2 Pediatric Cardiology Imaging
                        4.1.1.2.1 Fda’s Efforts to Bolster the Pediatric Cardiology Imaging Market
        4.1.2 Market Restraints
               4.1.2.1 Pediatric Interventional Cardiology Devices
                        4.1.2.1.1 Complex Regulatory Procedures
                        4.1.2.1.2 Varied Stringency of Regulatory Procedures Delays Product Launches
               4.1.2.2 Pediatric Cardiology Imaging
                        4.1.2.2.1 Implementation of Excise Tax By the U.S. Government
        4.1.3 Market Opportunities
               4.1.3.1 Pediatric Interventional Cardiology Devices
                        4.1.3.1.1 Advances In Biodegradable Devices for Pediatric Cardiology
                        4.1.3.1.2 Asia-Pacific Region Presents Significant Growth Opportunities
                        4.1.3.1.3 Robust Growth in the Transcatheter Heart Valves Market
               4.1.3.2 Pediatric Cardiology Imaging
                        4.1.3.2.1 Mobile Cath Labs, An Upcoming Opportunity Area
        4.1.4 Challenges
               4.1.4.1 Pediatric Interventional Cardiology Devices
                        4.1.4.1.1 Difficulties in Pediatric Clinical Trials
               4.1.4.2 Pediatric Cardiology Imaging
                        4.1.4.2.1 High Cost of Pediatric Interventional Cardiology Imaging Devices
                        4.1.4.2.2 Survival of Small Players and New Entrants
   4.2 Market Share Analysis
        4.2.1 Structural Heart Defect Closure Devices
        4.2.2 Transcatheter Heart Valves

5 Pediatric Interventional Cardiology Procedures (Page No. - 67)
   5.1 Introduction
   5.2 North America
   5.3 Europe
   5.4 APAC
   5.5 ROW

6 Pediatric Interventional Cardiology Devices Market (Page No. - 77)
   6.1 Introduction
   6.2 Heart Defect Closure Devices
        6.2.1 ASD, VSD, & PFO Closure Devices
               6.2.1.1 Atrial Septal Defect (ASD) Closure Devices
               6.2.1.2 Ventricular Septal Defect (VSD) Closure Devices
               6.2.1.3 Patent Foramen Ovale (PFO) Closure Devices
        6.2.2 Patent Ductus Arteriosus (Pda) Closure Devices
        6.2.3 Left Atrial Appendage (Laa) Closure Devices
   6.3 Transcatheter Heart Valves
        6.3.1 Transcatheter Pulmonary Valves
        6.3.2 Transcatheter Aortic Valves (TAV)
   6.4 Others
        6.4.1 Angioplasty Balloons
        6.4.2 Angioplasty Stents
        6.4.3 Catheters
        6.4.4 Guidewires

7 Geographic Analysis (Page No. - 130)
   7.1 Introduction
   7.2 Europe
        7.2.1 Germany
        7.2.2 France
        7.2.3 U.K.
        7.2.4 Italy
        7.2.5 Spain
        7.2.6 Roe
   7.3 North America
        7.3.1 U.S.
        7.3.2 Canada
   7.4 Asia-Pacific (APAC)
   7.5 Rest of the World (ROW)

8 Competitive Landscape (Page No. - 158)
   8.1 Pediatric Interventional Cardiology Imaging Market
        8.1.1 Introduction
        8.1.2 New Product Launches
        8.1.3 Acquisitions
        8.1.4 Agreements
        8.1.5 Expansions
        8.1.6 Approvals
   8.2 Pediatric Interventional Cardiology Devices Market
        8.2.1 Introduction
        8.2.2 Acquisitions
        8.2.3 Agreements
        8.2.4 New Product Launches
        8.2.5 Other Developments
        8.2.6 Approvals

9 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)* (Page No. - 176)
   9.1 Imaging Products Companies
        9.1.1 Ge Healthcare (Subsidiary of General Electric Company)
        9.1.2 Siemens Healthcare (Subsidiary of Siemens AG)
        9.1.3 toshiba Corporation
   9.2 Pediatric Interventional Cardiology Device Companies
        9.2.1 Edwards Lifesciences
        9.2.2 Gore Medical (Subsidiary of W.L. Gore & Associates)
        9.2.3 Medtronic, Inc.
        9.2.4 St. Jude Medical
        9.2.5 Abbott Vascular (A Subsidiary of Abbott Laboratories)
        9.2.6 Boston Scientific Corporation
        9.2.7 Cordis Corporation (Subsidiary of Johnson & Johnson)
        9.2.8 Numed, Inc.

*Details on Financials, Product & Services, Strategy, & Developments Might Not Be Captured in Case of Unlisted Companies.

List of Tables (90 Tables)

Table 1 Pediatric Interventional Cardiology Devices Market, By Geography, 2011-2018 ($Million)
Table 2 Number of Pediatric Interventional Cardiology Procedures, By Geography, 2012–2018
Table 3 Global Market, By Device Type, 2011–2018 ($Million)
Table 4 Pediatric Interventional Cardiology Devices Market, By Geography, 2011–2018 ($Million)
Table 5 North America: Pediatric Interventional Cardiology Devices Market, By Country, 2011–2018 ($Million)
Table 6 Europe: Pediatric Interventional Cardiology Devices Market, By Country, 2011–2018 ($Million)
Table 7 Heart Defect Closure Devices Market, By Device Type, 2011–2018 ($Million)
Table 8 Heart Defect Closure Devices Market, By Geography, 2011–2018 ($Million)
Table 9 North America: Heart Defect Closure Devices Market, By Country, 2011–2018 ($Million)
Table 10 Europe: Heart Defect Closure Devices Market, By Country, 2011–2018 ($Million)
Table 11 Pediatric ASD, VSD, & PFO Closure Devices Market, By Geography, 2011–2018 ($Million)
Table 12 North America: Pediatric ASD, VSD, & PFO Closure Devices Market, By Country, 2011–2018 ($Million)
Table 13 Europe: Pediatric ASD, VSD, & PFO Closure Devices Market, By Country, 2011–2018 ($Million)
Table 14 Major Atrial Septal Devices
Table 15 Major Ventricular Septal Defect Closure Devices
Table 16 Major Patent Foramen Ovale Closure Devices
Table 17 Major Patent Ductus Arteriosus Closure Devices
Table 18 Pediatric Pda Closure Devices Market, By Geography, 2011–2018 ($Million)
Table 19 North America: Pediatric Pda Closure Devices Market, By Country, 2011–2018 ($Million)
Table 20 Europe: Pediatric Pda Closure Devices Market, By Country, 2011–2018 ($Million)
Table 21 Major Left Atrial Appendage Closure Devices
Table 22 Pediatric Laa Closure Devices Market, By Geography, 2011–2018 ($Million)
Table 23 North America: Pediatric Laa Closure Devices Market, By Country, 2011–2018 ($Million)
Table 24 Europe: Pediatric Laa Closure Devices Market, By Country, 2011–2018 ($Million)
Table 25 Transcatheter Heart Valves Market, By Device Type, 2011–2018 ($Million)
Table 26 Transcatheter Heart Valves Market, By Geography, 2011–2018 ($Million)
Table 27 North America: Transcatheter Heart Valves Market, By Country, 2011–2018 ($Million)
Table 28 Europe: Transcatheter Heart Valves Market, By Country, 2011–2018 ($Million)
Table 29 Major Transcatheter Pulmonary Valve
Table 30 Pediatric Transcatheter Pulmonary Valve Device Market, By Geography, 2011–2018 ($Million)
Table 31 North America: Transcatheter Pulmonary Valves Market, By Country, 2011–2018 ($Million)
Table 32 Europe: Transcatheter Pulmonary Valves Market, By Country, 2011–2018 ($Million)
Table 33 Major Transcatheter Aortic Valves
Table 34 Pediatric Transcatheter Aortic Valve Device Market, By Geography, 2011–2018 ($Million)
Table 35 North America: Transcatheter Aortic Valves Market, By Country, 2011–2018 ($Million)
Table 36 Europe: Transcatheter Aortic Valves Market, By Country, 2011–2018 ($Million)
Table 37 Other Devices Market, By Geography, 2011–2018 ($Million)
Table 38 North America: Other Devices Market, By Country, 2011–2018 ($Million)
Table 39 Europe: Other Devices Market, By Country, 2011–2018 ($Million)
Table 40 Pediatric Interventional Cardiology Devices Market, By Geography, 2011–2018 ($Million)
Table 41 Europe: Market, By Device Type, 2011–2018 ($Million)
Table 42 Germany: Market, By Device Type, 2011–2018 ($Million)
Table 43 France: Market, By Device Type, 2011–2018 ($Million)
Table 44 U.K.: Market, By Device Type, 2011–2018 ($Million)
Table 45 Italy: Market, By Device Type, 2011–2018 ($Million)
Table 46 Spain: Market, By Device Type, 2011–2018 ($Million)
Table 47 Rest of Europe: Market, By Device Type, 2011–2018 ($Million)
Table 48 North America: Market, By Device Type, 2011–2018 ($Million)
Table 49 U.S.: Market, By Device Type, 2011–2018 ($Million)
Table 50 Canada: Market, By Device Type, 2011–2018 ($Million)
Table 51 Asia-Pacific (APAC): Market, By Device Type, 2011–2018 ($Million)
Table 52 ROW: Market, By Device Type, 2011–2018 ($Million)
Table 53 New Product Launch, 2011-2013
Table 54 Acquisitions, 2011-2013
Table 55 Agreements, 2011-2013
Table 56 Expansions, 2011-2013
Table 57 Approvals, 2011-2013
Table 58 Acqusitions, 2011-2013
Table 59 Agreements, 2011-2013
Table 60 New Product Launch, 2011-2013
Table 61 Other Developments, 2011-2013
Table 62 Approvals, 2011-2014
Table 63 General Electric: Total Revenue and R&D Expenditure, 2011–2013 ($Million)
Table 64 General Electric: Total Revenue, By Segment, 2011–2013 ($Million)
Table 65 General Electric: Total Revenue, By Geography, 2011–2013 ($Billion)
Table 66 Siemens Healthcare: Total Revenue and R&D Expenditure, 2011–2013 ($Million)
Table 67 Siemens Healthcare: Total Revenue, By Segment, 2011–2013 ($Million)
Table 68 Siemens Healthcare: Total Revenue, By Geography, 2011–2013 ($Million)
Table 69 Toshiba Corporation: Total Revenue and R&D Expenditure, 2011–2013 ($Billion)
Table 70 Toshiba Corporation: Total Revenue, By Segment, 2011–2013 ($Billion)
Table 71 Toshiba Corporation: Total Revenue, By Geography, 2011–2013 ($Billion)
Table 72 Edwards Lifesciences: Total Revenue and R&D Expenditure, 2010–2012 ($Million)
Table 73 Edwards Lifesciences: Total Revenue, By Segment, 2010–2012 ($Million)
Table 74 Edwards Lifesciences: Total Revenue, By Geography, 2010–2012 ($Million)
Table 75 Medtronic, Inc.: Total Revenue and R&D Expenditure, 2011–2013 ($Million)
Table 76 Medtronic, Inc.: Total Revenue, By Segment, 2011–2013 ($Million)
Table 77 Medtronic, Inc.: Total Revenue, By Geography, 2011–2013 ($Million)
Table 78 St. Jude Medical: Total Revenue and R&D Expenditure, 2011–2013 ($Million)
Table 79 St. Jude Medical: Total Revenue, By Segment, 2011–2013 ($Million)
Table 80 St. Jude Medical: Total Revenue, By Geography, 2011–2013 ($Million)
Table 81 Abbott Laboratories: Total Revenue and R&D Expenditure, 2011–2013 ($Million)
Table 82 Abbott Laboratories: Total Revenue, By Segment, 2011–2013 ($Million)
Table 83 Abbott Laboratories: Total Revenue, By Geography, 2011–2013 ($Million)
Table 84 Boston Scientific Corporation: Total Revenue and R&D Expenditure, 2011-2013 ($Million)
Table 85 Boston Scientific Corporation: Total Revenue, By Segment, 2011–2013 ($Million)
Table 86 Boston Scientific Corporation: Total Revenue, By Geography, 2011–2013 ($Million)
Table 87 Johnson & Johnson: Total Revenue and R&D Expenditure, 2011–2013 ($Million)
Table 88 Johnson & Johnson: Total Revenue, By Segment, 2011–2013 ($Million)
Table 89 Johnson & Johnson: Medical Devices and Diagnostic Segment Revenue, By Segment, 2011–2013 ($Million)
Table 90 Johnson & Johnson: Medical Devices and Diagnostic Segment Revenue, By Geography, 2011–2013 ($Million)

List of Figures (19 Figures)

Figure 1 Forecast Model
Figure 2 Market Size Estimation Methodology
Figure 3 Data Triangulation
Figure 4 Number of Pediatric Interventional Cardiology Procedures, 2012–2018
Figure 5 Major Patent Infringement Cases
Figure 6 Porter’s Five Forces Analysis
Figure 7 Market Dynamics
Figure 8 Structural Heart Defect Closure Devices Market Share Analysis, By Key Players, 2012
Figure 9 Transcatheter Heart Valve Market Share Analysis, By Key Player, 2012
Figure 10 Number of Pediatric Interventional Cardiology Procedures & Prevalence of CHD, By Geography, 2012–2018
Figure 11 North America: Number of Pediatric Interventional Cardiology Procedures, 2012–2018
Figure 12 Europe: Number of Pediatric Interventional Cardiology Procedures, 2012–2018
Figure 13 APAC: Number of Pediatric Interventional Cardiology Procedures, 2012–2018
Figure 14 ROW: Number of Pediatric Interventional Cardiology Procedures, 2012–2018
Figure 15 Pediatric Interventional Cardiology Devices Market, By Device Type
Figure 16 Other Devices
Figure 17 Pediatric Interventional Cardiology Devices Market, By Geography, 2013 ($Million)
Figure 18 Key Growth Strategies, Pediatric Interventional Cardiology Imaging Market, 2011–2014
Figure 19 Key Growth Strategies, Pediatric Interventional Cardiology Devices Market, 2011–2014

Customization Options:

With the above mentioned TOC, you can also customize the market data that meet your Company’s specific needs. Customize to get comprehensive industry standard and detailed analysis of the following parameters such as:

Country Level Market Data

• APAC (Japan, China, India, Australia and New Zealand, and Rest of Asia)
• Rest of the World (Latin America, Middle East, and Africa)

Names of Major Pediatric Cardiology Hospitals in

• U.S.
• France
• Germany
• Greece
• Italy
• Spain
• U.K.
• Rest of Europe
• Australia
• China
• India
• Japan
• Israel
• Malaysia
• New Zealand
• Rest of Asia

Product Analysis

• Comparison of major cardiac imaging systems
• Qualitative information regarding hybrid cath labs and the cost division involved constructing a hybrid cath lab